There was a significant correlation between tumors with the BRAF V600E mutation alone and the progression of distant metastatic disease after RAI therapy (p = 0.025), but TERT promoter mutations alone were not associated with PD (Fig. 2b). The gene discussed is BRAF; the disease is metastatic neoplasm.